Investors to AbbVie, J&J, Merck and more: Fork over info on pricing and executive pay

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 23, 2019 at 5:52 PM.

  1. #1 cafead, Apr 23, 2019 at 5:52 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via With shareholder resolutions at six top U.S. drugmakers—AbbVie, Celgene, Johnson & Johnson, Merck & Co., Pfizer and Vertex—the investors aim to learn how price changes factor into sales goals and other exec pay metrics. The resolutions, up for votes at the companies' annual meetings, ask the drugmakers whether they use price increases to meet their sales goals, whether boards must approve price hikes, and more.

    article source
     
    Quote

Reply to Thread